Dewey Steadman | Head-Investor Relations |
Martine Rothblatt | Chairperson & Chief Executive Officer |
Michael Benkowitz | President & Chief Operating Officer |
James Edgemond | Chief Financial Officer & Treasurer |
Leigh Peterson | Senior Vice President of Product Development |
Ash Verma | UBS |
Eun Yang | Jefferies |
Hartaj Singh | Oppenheimer |
Terence Flynn | Morgan Stanley |
Joseph Thome | TD Cowen |
Andreas Argyrides | Wedbush |
Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator today. [Operator Instructions] Please note, this call is being recorded.
I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thanks, Danielle, and good morning.